Literature DB >> 25682479

Profiles of substance use disorders in patients of therapeutic communities: link to social, medical and psychiatric characteristics.

David Fernández-Calderón1, Fermín Fernández2, Sofía Ruiz-Curado3, Antonio Verdejo-García4, Óscar M Lozano5.   

Abstract

BACKGROUND: Therapeutic community (TC) clients frequently display a pattern of multiple substance use disorders (SUDs) which is associated with poorer treatment outcomes. This study aimed to characterize multiple SUD profiles in patients enrolled in TCs, and examine the association of these profiles with social, medical and psychiatric outcomes.
METHODS: Observational study. We acquired substance use diagnoses and sociodemographic, medical and psychiatric comorbidity data for 4102 patients who had been admitted to six public TCs in Andalusia (Spain) from 2004 to 2012. Latent class analysis was applied to participants' substance use diagnoses, and the resulting classes were associated with social (i.e., education, employment, criminality), medical (i.e., infectious diseases) and psychiatric comorbidity.
RESULTS: We found four differentiated profiles of substance use diagnoses among TC patients: cocaine/opiates (Class 1: 37% of participants); cocaine/opiates/benzodiazepines (Class 2: 25.3%); alcohol (Class 3: 24.7%); and cocaine/cannabis/alcohol (Class 4: 12.9%). Classes 1 and 2 were associated with poorer social and medical characteristics. Class 2 was also associated with greater prevalence of impulsive spectrum mental disorders. Class 3 was associated with greater prevalence of mood and anxiety disorders and cognitive dysfunction, and Class 4 was associated with higher prevalence of psychotic illness.
CONCLUSIONS: Patients admitted to TCs have heterogeneous substance use diagnostic profiles. Profiles involving multiple use of heroin, cocaine, alcohol and benzodiazepines are associated with poorer social and medical function and impulse control disorders. Profiles involving alcohol use and cannabis/cocaine use are associated with cognitive dysfunction and psychotic illness respectively.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Comorbidity; Latent class analysis; Multiple substance use disorders

Mesh:

Year:  2015        PMID: 25682479     DOI: 10.1016/j.drugalcdep.2015.01.013

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  7 in total

1.  Polysubstance use profiles among electronic dance music party attendees in New York City and their relation to use of new psychoactive substances.

Authors:  Fermín Fernández-Calderón; Charles M Cleland; Joseph J Palamar
Journal:  Addict Behav       Date:  2017-11-04       Impact factor: 3.913

2.  Polysubstance Use Patterns among Justice-Involved Individuals Who Use Opioids.

Authors:  Amanda M Bunting; Carrie Oser; Michele Staton; Hannah Knudsen
Journal:  Subst Use Misuse       Date:  2020-07-20       Impact factor: 2.164

Review 3.  Cannabis and Psychosis: a Critical Overview of the Relationship.

Authors:  Charles Ksir; Carl L Hart
Journal:  Curr Psychiatry Rep       Date:  2016-02       Impact factor: 5.285

4.  Strain and cocaine-induced differential opioid gene expression may predispose Lewis but not Fischer rats to escalate cocaine self-administration.

Authors:  Marta Valenza; Roberto Picetti; Vadim Yuferov; Eduardo R Butelman; Mary Jeanne Kreek
Journal:  Neuropharmacology       Date:  2016-01-09       Impact factor: 5.250

5.  Dual cannabis and alcohol use disorders in young adults: Problems magnified.

Authors:  Jumi Hayaki; Bradley J Anderson; Michael D Stein
Journal:  Subst Abus       Date:  2016-04-12       Impact factor: 3.716

6.  Characteristics and Correlates of Psychiatric Problems in Wives of Men with Substance-related Disorders, Kermanshah, Iran.

Authors:  Toraj Ahmadi Juibari; Behrouz Behrouz; Mari Attaie; Vahid Farnia; Sanobar Golshani; Masuod Moradi; Mostafa Alikhani
Journal:  Oman Med J       Date:  2018-11

Review 7.  Investigating and addressing the immediate and long-term consequences of the COVID-19 pandemic on patients with substance use disorders: a scoping review and evidence map protocol.

Authors:  Leen Naji; Brittany Dennis; Rebecca L Morgan; Nitika Sanger; Andrew Worster; James Paul; Lehana Thabane; Zainab Samaan
Journal:  BMJ Open       Date:  2021-09-07       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.